Less than a week after The Blackstone Group joined a consortium reportedly comprising of The Carlyle Group and TPG Capital to bid for Australian hospital operator Healthscope, the company has received two additional offers from suitors, for an estimated value of about A$1.84 billion (€1.27 billion; $1.56 billion).
Kohlberg Kravis Roberts and CVC have made a joint bid for Healthscope, according to The Australian, while the second offer has been made by Tenet Healthcare, a trade buyer. KKR declined to comment. CVC could not be reached by press time.
Healthscope did not name the new bidders but disclosed that both bids were priced at A$5.80 per share, A$0.05 per share more than an existing proposal made by the private equity consortium, which had earlier offered A$5.50 per share to see its bid rejected by Healthscope and subsequently increased its offer to A$5.75 per share on 20 May.
Healthscope’s board is of the view that both new proposals are “equal to or superior to” the existing proposal made by the private equity consortium, it said in a filing with the Australian exchange. The new bidders will now be given the opportunity to conduct due diligence on Healthscope, it added.
The new offers represent a 10.9 percent premium over the company’s last closing share price of A$5.23 on Friday before the bids were received.
Healthscope shares were trading at A$5.49 at time of press.